GLB-001

A First-in-human, Phase 1, Dose Escalation and Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-risk Myelodysplastic Syndromes

Near Add Your Location

Center of Excellence

  • Accepting patients
  • Show Principal Investigator

Center of Excellence

  • Accepting patients

Center of Excellence

  • Accepting patients

Center of Excellence

  • Accepting patients
Chao Family Comprehensive Cancer Center
University of California, Irvine
Orange, CA
  • Accepting patients

Center of Excellence

  • Accepting patients

Center of Excellence

  • Accepting patients
  • Show Principal Investigator
501 hidden based on your filters. Show All

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.